Spinal Stimulation + Mobility Devices for Cerebral Palsy
Trial Summary
What is the purpose of this trial?
This research study will combine non-invasive spinal stimulation with mobility devices to examine the acute impact of the individual and combined effects of these innovative techniques on mobility in children with cerebral palsy.
Do I need to stop my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you have an implanted drug delivery device or are taking medication for osteoporosis, you may not be eligible to participate.
What data supports the effectiveness of the treatment Spinal Stimulation + Mobility Devices for Cerebral Palsy?
Research shows that power wheelchairs and mobility devices can improve independence in children with severe movement challenges, like those with dyskinetic cerebral palsy. Additionally, powered exoskeletons have been found to enhance mobility in individuals with spinal cord injuries, suggesting potential benefits for improving movement in cerebral palsy as well.12345
Is spinal stimulation and mobility device use generally safe for humans?
There are safety concerns with electrically propelled wheelchairs, as they may be unsafe. A system using neural stimulation during wheelchair use showed improved safety for users with spinal cord injuries. Exoskeleton-assisted walking can be safe but may cause adverse events like hypotension (low blood pressure) and fractures, requiring careful monitoring and training. Motorized mobility scooters also pose risks, including injuries and deaths.678910
How is the Spinal Stimulation + Mobility Devices treatment for Cerebral Palsy different from other treatments?
This treatment is unique because it combines spinal cord stimulation, which uses electrical pulses to target specific areas of the spinal cord, with mobility devices to potentially improve movement in individuals with cerebral palsy. Unlike traditional treatments that may focus solely on physical therapy or medication, this approach integrates advanced technology to directly influence the nervous system.1112131415
Research Team
Katherine M Steele, PhD
Principal Investigator
University of Washington
Eligibility Criteria
This trial is for children and adults aged 4-70 with cerebral palsy or other brain-related conditions who can follow simple instructions and are medically stable. It's not for those with rheumatic diseases, active cancer, implanted stimulators or drug delivery devices, recent orthopedic surgery in the legs, uncontrolled seizures, severe osteoporosis on treatment, or significant cardiovascular issues.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive non-invasive spinal stimulation and use mobility devices to evaluate their combined effects on mobility
Follow-up
Participants are monitored for changes in muscle strength, spasticity, and muscle coordination
Treatment Details
Interventions
- Mobility Device
- Spinal Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
Seattle Children's Hospital
Collaborator